Oxaliplatin

Oxaliplatin is an organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane (DACH) and with an oxalate ligand as a ‘leaving group.’ A ‘leaving group’ is an atom or a group of atoms that is displaced as a stable species taking with it the bonding electrons. After displacement of the labile oxalate ligand leaving group, active oxaliplatin derivatives, including monoaquo and diaquo DACH platinum, alkylate macromolecules, forming both inter- and intra-strand platinum-DNA crosslinks, which result in inhibition of DNA replication and transcription and cell-cycle nonspecific cytotoxicity. The DACH side chain appears to inhibit alkylating-agent resistance. It is grouped under the following drug class(es): Alkylating agents, Antineoplastic agents, Cytotoxics and Platinum compounds. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Oxalato(trans-l-1, 2-cyclohexanediamine)platinum(II), cis-oxalato-trans-l-1 and 2-diaminocyclohexaneplatinum(II). Its PubChem CID is 9887053.

CAS No 61825-94-3
Molecular Formula C8H14N2O4Pt
Molecular Weight 397.29 g/mol
Synonyms [(1R,2R)-2-azanidylcyclohexyl]azanide;oxalic acid;platinum(2+)

Frequently Asked Questions